H02.88 Meibomian gland dysfunction of eyelid

Name of the Condition

• Meibomian Gland Dysfunction of Eyelid

Summary

Meibomian gland dysfunction (MGD) is a common condition affecting the meibomian glands in the eyelids, which are responsible for producing the oily layer of the tear film. This dysfunction can lead to dry, irritated eyes and other ocular surface issues due to inadequate lubrication.

Causes

MGD is primarily caused by blockages or structural changes in the meibomian glands. These changes may result from aging, hormonal imbalances, chronic inflammation, or underlying skin conditions like rosacea. Abnormal secretion or thickening of glandular secretions can also contribute to the condition.

Risk Factors

• Aging, as gland function tends to decline with time.
• Hormonal fluctuations, particularly in post-menopausal individuals.
• History of inflammatory skin conditions, such as rosacea or seborrheic dermatitis.
• Use of contact lenses or certain medications that affect tear production.
• Prolonged screen time, which reduces blink rate and may exacerbate symptoms.

Symptoms

• Dryness, irritation, or a gritty sensation in the eyes.
• Blurred vision or sensitivity to light.
• Redness, swelling, or inflammation of the eyelids.
• Excessive tearing or crusting along the eyelid margins.
• Discomfort or burning sensation, especially upon waking.

Diagnosis

Diagnosis is typically based on a clinical examination by an eye care professional, which may include evaluating eyelid margins, gland expressibility, and tear film quality. Specialized tests, such as meibography or tear osmolarity measurements, may be used to assess gland structure and function.

Treatment Options

• Warm compresses and eyelid massages to unclog gland ducts.
• Eyelid hygiene practices, including gentle cleaning with lid scrubs.
• Artificial tears or lubricating eye drops to alleviate dryness.
• Prescription medications, such as anti-inflammatory drops or antibiotics, for associated inflammation or infection.
• Omega-3 fatty acid supplements to improve gland function and reduce inflammation.

Prognosis and Follow-Up

With proper management, symptoms often improve, but MGD is typically chronic and may require ongoing treatment. Regular follow-up with an eye care provider is recommended to monitor gland function and adjust therapy as needed. Long-term care may be necessary to prevent recurrence or progression.

Complications

Untreated MGD can lead to chronic dry eye, corneal irritation, or increased risk of eye infections. Severe cases may result in eyelid inflammation (blepharitis) or damage to the ocular surface.

Lifestyle & Prevention

• Maintain good eyelid hygiene by cleaning the eyelid margins regularly.
• Use warm compresses and gentle massages to promote gland function.
• Avoid eye makeup or cosmetics that may clog gland ducts.
• Take breaks during prolonged screen use to reduce eye strain.
• Stay hydrated and consider dietary adjustments, such as increasing omega-3 intake.

When to Seek Professional Help

Seek medical attention if symptoms persist despite home care, worsen over time, or are accompanied by severe pain, vision changes, or signs of infection (e.g., pus, increased redness). Prompt evaluation is important for managing complications and preventing long-term damage.

Tips for Medical Coders

When coding for meibomian gland dysfunction of the eyelid (H02.88), ensure documentation specifies the affected eye and eyelid (e.g., right/left, upper/lower) if applicable. Note any associated conditions, such as blepharitis or dry eye syndrome, as these may influence coding and reimbursement. Verify that the diagnosis aligns with clinical findings and that all relevant details are captured in the medical record.